Rescue percutaneous repair of ischemic acute severe mitral regurgitation.
Acute myocardial infarction/STEMI
Cardiogenic shock
Choque cardiogénico
Doença valvular mitral
Enfarte agudo do miocárdio
Heart failure
Insuficiência cardíaca
Intervenção percutânea
Mitral valve disease
Percutaneous intervention
Journal
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
ISSN: 2174-2030
Titre abrégé: Rev Port Cardiol
Pays: Portugal
ID NLM: 8710716
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
09
06
2019
revised:
03
12
2019
accepted:
22
02
2020
entrez:
5
9
2022
pubmed:
6
9
2022
medline:
6
9
2022
Statut:
ppublish
Résumé
Acute severe mitral regurgitation (MR) because of secondary left ventricular impaired regional contractility can present with severe acute heart failure, associated with a high risk for rapid decompensation, pulmonary edema and cardiogenic shock. Frequently, in these highly unstable patients, surgical risk can be prohibitive. Evidence for percutaneous repair of acute MR is scarce, but a few case series show that this approach could be safe and effective for bailing out hemodynamically unstable patients. We report a case of an 84-year-old man with acute ischemic severe MR post-acute myocardial infarction (MI), who remained hemodynamically unstable despite coronary revascularization, positive pressure non-invasive ventilation, vasodilator therapy and intra-aortic balloon pump (IABP) support. In heart team discussions, he was considered a high risk surgical candidate. We decided on rescue off-label percutaneous mitral valve repair with a MitraClip device (Abbott Vascular, Santa Clara, California), with good clinical result, allowing weaning from the supports and discharge seven days after the procedure. At one-year follow-up, the patient maintained a MV repair results and had a good functional status. In unstable patients with acute ischemic MR, percutaneous MV repair could be a rescue therapeutic option to consider, allowing hemodynamic compensation with potential persistent MR improvement up to one-year follow-up.
Identifiants
pubmed: 36062670
pii: S0870-2551(22)00022-1
doi: 10.1016/j.repc.2020.02.015
pii:
doi:
Types de publication
Case Reports
Langues
eng
por
Pagination
349.e1-349.e6Informations de copyright
Copyright © 2022 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.